Clinical data showed that high TUG1 expression was significantly correlated with larger tumor size (P < 0.001), advanced FIGO stage (P = 0.009), poor differentiation (P = 0.007), and lymph node metastasis (P = 0.015), but not with other clinicopathological factors, such as age, histologic type, and the level of serum squamous cell carcinoma antigen (SCC‐Ag; P > 0.05). The gene discussed is TUG1; the disease is metastatic malignant neoplasm in the lymph nodes.